Brookfield Corporation (BN) concluded trading on Thursday at a closing price of $48.64, with 4.66 million shares of worth about $226.52 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 2.96% during that period and on March 13, 2025 the price saw a loss of about -3.26%. Currently the company’s common shares owned by public are about 1.65B shares, out of which, 1.36B shares are available for trading.
Stock saw a price change of -7.49% in past 5 days and over the past one month there was a price change of -17.11%. Year-to-date (YTD), BN shares are showing a performance of -15.34% which increased to 15.62% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $38.18 but also hit the highest price of $62.78 during that period. The average intraday trading volume for Brookfield Corporation shares is 2.51 million. The stock is currently trading -13.09% below its 20-day simple moving average (SMA20), while that difference is down -15.48% for SMA50 and it goes to -6.60% lower than SMA200.
Brookfield Corporation (NYSE: BN) currently have 1.65B outstanding shares and institutions hold larger chunk of about 56.25% of that.
The stock has a current market capitalization of $80.07B and its 3Y-monthly beta is at 1.62. PE ratio of stock for trailing 12 months is 161.59, while it has posted earnings per share of $0.30 in the same period. Its PEG reads 10.43 while making debt-to-equity ratio of 5.11. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BN, volatility over the week remained 3.78% while standing at 3.02% over the month.
Stock’s fiscal year EPS is expected to drop by -3.07% while it is estimated to increase by 20.02% in next year. EPS is likely to grow at an annualized rate of 15.49% for next 5-years, compared to annual growth of -29.74% made by the stock over the past 5-years.
On March 20, 2023, Credit Suisse Upgrade their recommendations, while on February 06, 2023, Credit Suisse Downgrade their ratings for the stock with a price target of $41.
